inhalers

Pharmacy inhaler disposal pilot boosts return rates by 300pc

Reminder stickers encouraged patients to return unwanted and expired inhalers.

Inhaler company announces carbon neutral respiratory portfolio

Carbon minimal inhaler expected to launch in 2025, says Chiesi

Pharmacy Magazine Podcast - Category Insight: Asthma

We're back! This month covering all things asthma... with advice from Asthma + Lung UK.

Minimising the environmental impact of inhalers

Around 3 per cent of the NHS carbon footprint is produced by inhalers. The main driver is the propellant gases contained inside pressurised metered dose inhalers. By Morag Punton.

Covid's legacy in older people with asthma

One in seven older adults with asthma experienced depression for the first time during the Covid-19 pandemic, according to Canadian research.

Help to tackle reliever inhaler overuse

Community pharmacies may hold the key to improving patients' understanding of their asthma.

Help to tackle reliever overuse

More than one million people are overusing their reliever inhalers with those in the poorest communities most likely to miss out on getting the support they need to manage their asthma effectively, says Dr Andy Whittamore, who is clinical lead at Asthma + Lung UK

Management of uncontrolled asthma in community pharmacy

The Taskforce for Lung Health is calling on policymakers and commissioners to provide extra funding to help community pharmacies deliver regular – and improved – care for the millions of people in the UK living with asthma.

Inhaler recycling scheme expands to hospitals

Almost two-thirds of Leicestershire pharmacies have signed up to the scheme.

Asthma exacerbation rates fall during pandemic

Fewer people with severe asthma attacks were admitted to hospital or seen by their GP during the Covid-19 pandemic.

Asthma exacerbation rates fall during pandemic

Fewer people with severe asthma attacks were admitted to hospital or seen by their GP during the Covid-19 pandemic.

Benefits of steroids in inhalers outweighs risk say researchers

The advantages of using inhalers and nebulisers containing steroids outweigh the risks, claim researchers. 

 

Inhalers and insulin dominate new export ban products

Asthma medications and insulin products make up the vast majority of the medicines newly added to the DHSC’s parallel export ban list.

Reusable inhalers ‘could reduce NHS carbon footprint’

The newly launched reusable Respimat inhalers can be used with up to six refill cartridges.

Inhalers and antidepressants most common NUMSAS items

The number of referrals made through the NHS Urgent Medicine Supply Advanced Service (NUMSAS) has more than doubled in the past year.

NICE goes green on asthma inhalers

Metered dose inhalers, containing hydrofluorocarbons, have estimated carbon footprints of 500g CO2eq per dose, compared to 20g in dry powder inhalers.